-+ 0.00%
-+ 0.00%
-+ 0.00%

At the 2026 Zhangjiang Pharmaceutical Valley Conference and Shanghai International Biomedical Industry Week, which opened on September 17, the Shanghai Securities News reporter interviewed people in the pharmaceutical industry and learned that as the scale of innovative drug BD transactions continues to expand and innovative achievements accelerate, China is gradually growing from a major global biomedical market to an important force in the global innovation landscape. In the next stage, how to truly transform innovative results into treatment plans accessible to patients will become a new issue faced by all parties. The data shows that since this year, the number and amount of innovative drug BD transactions have continued to reach new highs. From January to August, there were 113 biomedical BD transactions, with a total amount of US$119.097 billion. The number of biomedical BD transactions in Shanghai was 37, accounting for 33% of the country, ranking first in the country; the total amount of BD was 18.230 billion US dollars, accounting for 15% of the country, ranking third in the country.

Zhitongcaijing·09/18/2026 23:33:03
Listen to the news
At the 2026 Zhangjiang Pharmaceutical Valley Conference and Shanghai International Biomedical Industry Week, which opened on September 17, the Shanghai Securities News reporter interviewed people in the pharmaceutical industry and learned that as the scale of innovative drug BD transactions continues to expand and innovative achievements accelerate, China is gradually growing from a major global biomedical market to an important force in the global innovation landscape. In the next stage, how to truly transform innovative results into treatment plans accessible to patients will become a new issue faced by all parties. The data shows that since this year, the number and amount of innovative drug BD transactions have continued to reach new highs. From January to August, there were 113 biomedical BD transactions, with a total amount of US$119.097 billion. The number of biomedical BD transactions in Shanghai was 37, accounting for 33% of the country, ranking first in the country; the total amount of BD was 18.230 billion US dollars, accounting for 15% of the country, ranking third in the country.